Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

AMGEN (AMGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
11:38a PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
11:38a NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15 Germany's Merck in fresh bid to enter U.S. MS pill market
12/15DJTEVA PHARMACEUTICAL INDUSTRIES : Generics Giant Cuts Staff by 25% -- WSJ
12/15DJNOVARTIS : Oncology CEO Bruno Strigini to Retire
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/15 Wall Street falls as investors fret about tax bill passage
12/14 TSX in broad retreat led by Cenovus, other energy stocks
12/14 Perrigo lines up bid for Merck's consumer health unit - sources
12/14 TEVA PHARMACEUTICAL INDUSTRIES : Pharm to lay off a quarter of workforce, suspen..
12/14DJTEVA PHARMACEUTICAL INDUSTRIES : to Cut 14,000 Jobs, Suspend Dividend -- Update
12/14DJTEVA PHARMACEUTICAL INDUSTRIES : to Cut 14,000 Jobs
12/14DJGLAXOSMITHKLINE : GSK Applies for Australian Approval of Malaria Treatment
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/13DJELI LILLY AND : Sees Modest Revenue Growth in 2018
12/13 SANOFI : CEO says M&A targets in oncology are 'very expensive'
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/13DJSANOFI : to Begin at Least 10 Phase 3 Studies Over Next 12 Months
12/13 SANOFI : Did Sanofi, WHO ignore warning signals on dengue vaccine?
12/12 Sanofi investors hungry for drug progress and deal news
12/12DJMERCK : Appoints Allan Gabor as Managing Director in China
12/12DJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
12/12DJSANOFI : Receives U.S. FDA Approval for Insulin Injection Admelog
12/12DJGLAXOSMITHKLINE : Nucala gets FDA Approval for EGPA
12/12 Monsanto offers cash to U.S. farmers who use controversial chemical
12/11 ASTRAZENECA : GSK's new pharma head on lookout for cancer deals to boost pipelin..
12/11DJSANOFI : Urges Philippines to Lift Dengue Vaccine Suspension -AFP
12/11 Merck raises stakes in lung cancer as rivals close in
12/11DJROCHE : Reports Positive Results From IMmotion151 Kidney Cancer Trial
12/11 ROCHE : Tecentriq cocktail slows kidney cancer progression
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 ALEXION PHARMACEUTICALS : Elliott Management seeks changes at Alexion - NYT
12/08 Wall Street closes higher after payrolls report
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08DJSHIRE : Names John Miller as Interim CFO From Jan. 1
12/08DJTEVA PHARMACEUTICAL INDUSTRIES : May Cut Up to 10,000 Jobs -Bloomberg
12/08DJSHIRE PLC SHIRE PLC : Directorate Change
12/08DJROCHE : Novartis's Italian Heads Risk Trial for Alleged Market Rigging -Reuters
12/08 ROCHE, NOVARTIS' ITALIAN HEADS RISK : sources
12/08DJSANOFI : Signs Agreement to Produce Vaccines in Algeria
12/08 SANOFI : Philippines to seek refund of $59 million from Sanofi amid vaccine risk
12/07 TSX gains in broad rally led by financials, energy stocks
12/07 Comeback in banks, tech lifts euro zone stocks as Steinhoff collapses
12/07 Roche drug cocktail doubles chance of holding lung cancer at bay
12/07 Whitbread jumps after hedge fund Sachem Head declares stake
12/07 Companies prepare for disorderly Brexit as talks stall
Financials ($)
Sales 2017 22 886 M
EBIT 2017 11 755 M
Net income 2017 8 326 M
Finance 2017 6 819 M
Yield 2017 2,55%
P/E ratio 2017 15,73
P/E ratio 2018 15,67
EV / Sales 2017 5,32x
EV / Sales 2018 5,13x
Capitalization 129 B
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
AMGEN21.32%128 515
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386
SANOFI-4.07%109 152
BAYER6.02%103 473
BRISTOL-MYERS SQUIBB COMPANY8.61%102 146
NOVO NORDISK A/S29.37%102 077
ABBOTT LABORATORIES42.49%96 603
ELI LILLY AND COMPANY19.50%95 289
CELGENE CORPORATION-6.52%86 140
GLAXOSMITHKLINE-17.09%84 827
ASTRAZENECA9.99%82 988
ALLERGAN PLC-19.41%57 098
SHIRE-21.33%45 962
TAKEDA PHARMACEUTICAL CO LTD28.65%43 682
CHUGAI PHARMACEUTICAL CO LTD74.07%29 167
JIANGSU HENGRUI MEDICINE CO LTD53.05%28 792
ASTELLAS PHARMA INC-11.93%26 292